---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-014627"
form_type: "8-K"
ticker: "SABS"
cik: "0001833214"
company_name: "SAB Biotherapeutics, Inc."
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:50:06.674296+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# SAB Biotherapeutics enters 5-year lease for Sioux Falls lab/office space from Sanford Health

## Summary
- Leases 21,014 sq ft at 2301 E 60th St N, Sioux Falls, SD; term effective Feb 1, 2025 through Dec 31, 2029.
- Annual rent $601,630.82 ($28.63/sq ft), paid monthly at $50,135.90; January 2025 rent paid under prior lease.
- Annual rent escalates by greater of 2% or CPI starting Jan 1, 2026; either party may terminate with 90 days' notice.
- Tenant responsible for maintenance and repairs; Landlord pays utilities, taxes, and base-building maintenance.

## SEC filing metadata
- accession: 0000950170-25-014627
- form_type: 8-K
- ticker: SABS
- cik: 0001833214
- company_name: SAB Biotherapeutics, Inc.
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833214/000095017025014627/0000950170-25-014627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833214/000095017025014627/sabs-20250130.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-014627
- JSON: https://secwatch.observer/filing/0000950170-25-014627.json
- Plain text: https://secwatch.observer/filing/0000950170-25-014627.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.